🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Lakewood-Amedex Biotherapeutics, Inc. (LABT)
NASDAQ: LABT · Real-Time Price · USD
0.2522
+0.0393 (18.46%)
Nov 20, 2026, 9:55 AM EST - Market open

LABT Stock Forecast

Stock Price Forecast

According to 2 analysts polled by S&P Global, LABT stock has an average price target of $7.50. The average 1-year stock price forecast is 2,873.83% higher than the current stock price, while the lowest is $3.00 (+1,089.53%) and the highest is $12 (+4,658.13%).

Price Target: $7.50 (+2,873.83%)
Analyst Consensus: n/a

Price Target

Chart
TargetLowAverageMedianHigh
Price$3.00$7.50$7.50$12
Change+1089.5%+2873.8%+2873.8%+4658.1%

Analyst Ratings

According to 1 stock analyst, the rating for LABT is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJun '26Aug '26Sep '26Oct '26Nov '26
Strong Buy00011
Buy00000
Hold00000
Sell00000
Strong Sell00000
Total00011

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$3
BuyReiterates$3+1,089.53%Nov 17, 2026

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-4.96
from -8.40
EPS Next Year
-0.96
from -4.96
Fiscal YearFY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
----
Operating Income
-8.64M-4.03M-3.77M-8.00M
Net Income
-8.28M-4.86M-3.85M-8.80M
EPS
-12.16-9.92-8.40-4.96
No. Analysts
---2

Revenue Forecast

Revenue202620272028
Highn/a
Avgn/a
Lown/a

Revenue Growth

Revenue Growth20272028
High-
Avg-
Low-

EPS Forecast

EPS202620272028
High-4.96
Avg-4.96
Low-4.96

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-